Torsades de Pointe Caused by Drug Clinical Trial
Official title:
A Pharmacovigilance Study of Torsade de Pointes in the Food and Drug Administration Adverse Event Reporting System Using Data Mining Algorithms
Many cardiac and non-cardiac drugs are associated with TdP that may constitute a significant problem because of sudden cardiac death. This study aims to present a comprehensive overview and disproportionality analysis of TdP cases reported to the Food and Drug Administration Adverse Event Reporting System (FAERS) in order to identify new signals of TdP.
Drug-induced Torsade de Pointes (TdP) is a serious but an overlooked adverse drug reaction because a wide range of marketed drugs associated with TdP are commonly prescribed in routine practice. Owing to the heightened concern of a vast number of drug-TdP associations including newly approved drugs, the investigators, therefore, aims to investigate drug-TdP associations by performing disproportionality analysis in order to identify new signals of TdP utilizing the individual case reports of TdP in the FAERS database. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04336644 -
Continuous Versus Intermittent cARdiac Electrical moNitorinG
|
N/A | |
| Not yet recruiting |
NCT04437901 -
COVIDAR - Arrhythmias in COVID-19
|